English | Español

Biospace
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
Patient Daily | Jan 7, 2026

Ultragenyx faces setback as key bone drug fails late-stage trial
Patient Daily | Jan 7, 2026

Pfizer leads U.S. drugmakers in planned price increases for 2026
Patient Daily | Jan 7, 2026

FDA approves Vanda's Nereus as first new motion sickness drug in four decades
Patient Daily | Jan 7, 2026

BioSpace announces NextGen Class of 2026 highlighting top biotech startups
Patient Daily | Jan 6, 2026

Biotech IPO activity slows sharply in 2025 as investor scrutiny increases
Patient Daily | Jan 6, 2026

FDA increasingly diverged from advisory panel advice while holding fewer meetings in 2025
Patient Daily | Jan 6, 2026

Pharma faces continued uncertainty over drug pricing despite most favored nation deals

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Regulatory
Patient Daily | Mar 12, 2026

Texas Medical Association announces concerns over pharmacy benefit manager consolidation
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech